Deciphera Pharmaceuticals Inc
NASDAQ:DCPH
Deciphera Pharmaceuticals Inc
NASDAQ:DCPH
Price:
25.54 USD
0.04%
Updated:
Jun 3, 2024
Deciphera Pharmaceuticals Inc
Other Long-Term Assets
|
Deciphera Pharmaceuticals Inc
Other Long-Term Assets Peer Comparison
Comparables:
ABBV
GILD
AMGN
VRTX
REGN
Competitive Other Long-Term Assets Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Other Long-Term Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Deciphera Pharmaceuticals Inc
NASDAQ:DCPH
|
Other Long-Term Assets
$8.1m
|
CAGR 3-Years
38%
|
CAGR 5-Years
50%
|
CAGR 10-Years
N/A
|
|
|
Abbvie Inc
NYSE:ABBV
|
Other Long-Term Assets
$9.1B
|
CAGR 3-Years
24%
|
CAGR 5-Years
51%
|
CAGR 10-Years
27%
|
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Other Long-Term Assets
$4.8B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
14%
|
CAGR 10-Years
25%
|
|
|
Amgen Inc
NASDAQ:AMGN
|
Other Long-Term Assets
$9B
|
CAGR 3-Years
16%
|
CAGR 5-Years
39%
|
CAGR 10-Years
19%
|
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Other Long-Term Assets
$2.8B
|
CAGR 3-Years
49%
|
CAGR 5-Years
13%
|
CAGR 10-Years
75%
|
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Other Long-Term Assets
$3.2B
|
CAGR 3-Years
55%
|
CAGR 5-Years
27%
|
CAGR 10-Years
29%
|
See Also
What is Deciphera Pharmaceuticals Inc's Other Long-Term Assets?
Other Long-Term Assets
8.1m
USD
8.1m
USD
Based on the financial report for Mar 31, 2024, Deciphera Pharmaceuticals Inc's Other Long-Term Assets amounts to 8.1m USD.
What is Deciphera Pharmaceuticals Inc's Other Long-Term Assets growth rate?
Other Long-Term Assets CAGR 5Y
50%
50%
Over the last year, the Other Long-Term Assets growth was 148%. The average annual Other Long-Term Assets growth rates for Deciphera Pharmaceuticals Inc have been 38% over the past three years , 50% over the past five years .
You don't have any saved screeners yet
